Stockreport

Biomea Fusion to Become a Diabetes & Obesity Medicines Company

Biomea Fusion, Inc.  (BMEA) 
PDF Icovamenib & BMF-650 (oral small molecule GLP-1) are the cornerstones of the metabolic franchiseBiomea preparing icovamenib for late-stage clinical development2025 corpo [Read more]